MESO
Mesoblast limited.

5,299
Mkt Cap
$3.22B
Volume
38,684.00
52W High
$22.00
52W Low
$7.09
PE Ratio
-19.34
MESO Fundamentals
Price
$16.47
Prev Close
$16.36
Open
$16.32
50D MA
$16.32
Beta
1.40
Avg. Volume
298,865.33
EPS (Annual)
-$0.8443
P/B
3.50
Rev/Employee
$211,960.04
Loading...
Loading...
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
81

Frequently Asked Questions

What is Market Cap of Mesoblast Ltd - ADR?
What is the 52-week high for Mesoblast Ltd - ADR?
What is the 52-week low for Mesoblast Ltd - ADR?
What is Mesoblast Ltd - ADR stock price today?
What was Mesoblast Ltd - ADR stock price yesterday?
What is the PE ratio of Mesoblast Ltd - ADR?
What is the Price-to-Book ratio of Mesoblast Ltd - ADR?
What is the 50-day moving average of Mesoblast Ltd - ADR?
How many employess does Mesoblast Ltd - ADR has?

Latest MESO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.